India market brief
Invest with understanding.
Research the business. See the risks. Keep a record of what would change your mind.
India market benchmark
Nifty 50
Latest level—
Day's move—
SnapshotPeriod start—
Period high—
Period low—
Period return—
Loading Nifty 50 history…
The chart is sourced from the market snapshot.
Market breadth
Sector pulse
Current boardToday's board
Watchlist radar
Pick a preset or add filters. Percentages are typed as percentages and market cap in crore.
Goal arithmetic
Rule of 72, and the exact figureTen lakh to one crore is a 10x multiple. Enter your own numbers to see the rate it needs and how long each rate takes.
NSE · Pharmaceuticals
Ambalal Sarabhai Enterprises Limited (AMBALALSA)
₹34.83
Ratios use the ₹34.83 NSE close of 3 Nov 2026.
- Market cap
- ₹267 Cr
- P/E
- 15.48
- trailing 4 quarters (0 filed) to Mar 2026
- P/B
- 1.69
- 52-week range
- ₹30.15 – ₹49.98
- ROE
- 11.24%
- Operating margin
- 11.46%
- Debt to equity
- 35.7%
Built from 4 annual years from the data vendor; 5 quarters from the data vendor through 31 Mar 2026.
Research output built from exchange filings. ArthaPrime does not issue price targets, recommendations, or investment advice.